Dyne Therapeutics, Inc. Common Stock (DYN)
PHARMACEUTICAL PREPARATIONS
Dyne Therapeutics, Inc. Common Stock (DYN) is listed on Nasdaq, where it has traded since September 17, 2020.
- Listed On
- Nasdaq
- Listed Since
- September 17, 2020
- Employees
- 258
- Market Cap
- $3.0B
About Dyne Therapeutics, Inc. Common Stock
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease being treated, a linker, and an antigen-binding fragment that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 239 institutions reported holding DYN, with 190.6 million shares worth $4.2 billion in aggregate. The largest reported holder was T. Rowe Price, with 34.8 million shares worth $774.0 million. Of the 5 largest holders listed below, 1 opened a new position in DYN, 3 added shares and 1 reduced its position during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| T. Rowe Price | 34,849,093 | $774M | Added 5.24% |
| BlackRock | 12,404,330 | $276M | Added 6.02% |
| Jupiter Topco | 11,997,738 | $267M | New position |
| Vanguard | 11,520,878 | $256M | Reduced 1.29% |
| FMR | 11,207,000 | $249M | Added 25.79% |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is DYN?
Dyne Therapeutics, Inc. Common Stock (DYN) is listed on Nasdaq, where it has traded since September 17, 2020.
Who are the largest institutional holders of DYN?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of DYN were T. Rowe Price, BlackRock and Jupiter Topco.
How many institutions own DYN?
239 institutions reported a position in DYN for the quarter ended June 30, 2026, worth $4.2 billion in total.
Did institutions buy or sell DYN last quarter?
Of the 5 largest reported holders, 1 opened a new position in DYN, 3 added shares and 1 reduced its position during the quarter. Every reported holder and its change is on the SentiSense ownership page for DYN.
Every reported institutional holder, plus insider and congressional trades in DYN, on SentiSense.